|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yao Z, Painter SL, Fanslow WC, Ulrich D,
Macduff BM, Spriggs MK and Armitage RJ: Human IL-17: A novel
cytokine derived from T cells. J Immunol. 155:5483–5486.
1995.PubMed/NCBI
|
|
3
|
Gaffen SL: An overview of IL-17 function
and signaling. Cytokine. 43:402–407. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gerhardt S, Abbott WM, Hargreaves D,
Pauptit RA, Davies RA, Needham MR, Langham C, Barker W, Aziz A,
Snow MJ, et al: Structure of IL-17A in complex with a potent, fully
human neutralizing antibody. J Mol Biol. 394:905–921. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Omrane I, Medimegh I, Baroudi O, Ayari H,
Bedhiafi W, Stambouli N, Ferchichi M, Kourda N, Bignon YJ,
Uhrhammer N, et al: Involvement of IL17A, IL17F and IL23R
polymorphisms in colorectal cancer therapy. PLoS One.
10:e01289112015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu B, Guenther JF, Pociask DA, Wang Y,
Kolls JK, You Z, Chandrasekar B, Shan B, Sullivan DE and Morris GF:
Promotion of lung tumor growth by interleukin-17. Am J Physiol Lung
Cell Mol Physiol. 307:L497–L508. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Slattery ML, Herrick JS, Torres-Mejia G,
John EM, Giuliano AR, Hines LM, Stern MC, Baumgartner KB, Presson
AP and Wolff RK: Genetic variants in interleukin genes are
associated with breast cancer risk and survival in a genetically
admixed population: The Breast Cancer Health Disparities Study.
Carcinogenesis. 35:1750–1759. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dai ZM, Zhang TS, Lin S, Zhang WG, Liu J,
Cao XM, Li HB, Wang M, Liu XH, Liu K, et al: Role of IL-17A
rs2275913 and IL-17F rs763780 polymorphisms in risk of cancer
development: An updated meta-analysis. Sci Rep. 6:204392016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gomes AL, Teijeiro A, Burén S, Tummala KS,
Yilmaz M, Waisman A, Theurillat JP, Perna C and Djouder N:
Metabolic inflammation-associated IL-17A causes non-alcoholic
steatohepatitis and hepatocellular carcinoma. Cancer Cell.
30:161–175. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chang SH, Mirabolfathinejad SG, Katta H,
Cumpian AM, Gong L, Caetano MS, Moghaddam SJ and Dong C: T helper
17 cells play a critical pathogenic role in lung cancer. Proc Natl
Acad Sci USA. 111:5664–5669. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin WW and Karin M: A cytokine-mediated
link between innate immunity, inflammation, and cancer. J Clin
Invest. 117:1175–1183. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tong Z, Yang XO, Yan H, Liu W, Niu X, Shi
Y, Fang W, Xiong B, Wan Y and Dong C: A protective role by
interleukin-17F in colon tumorigenesis. PLoS One. 7:e349592012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kulig P, Burkhard S, Mikita-Geoffroy J,
Croxford AL, Hövelmeyer N, Gyülvészi G, Gorzelanny C, Waisman A,
Borsig L and Becher B: IL17A-mediated endothelial breach promotes
metastasis formation. Cancer Immunol Res. 4:26–32. 2016. View Article : Google Scholar
|
|
14
|
Meirovitz A, Goldberg R, Binder A,
Rubinstein AM, Hermano E and Elkin M: Heparanase in inflammation
and inflammation-associated cancer. FEBS J. 280:2307–2319. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vlodavsky I, Beckhove P, Lerner I, Pisano
C, Meirovitz A, Ilan N and Elkin M: Significance of heparanase in
cancer and inflammation. Cancer Microenviron. 5:115–132. 2012.
View Article : Google Scholar :
|
|
16
|
Boyango I, Barash U, Naroditsky I, Li JP,
Hammond E, Ilan N and Vlodavsky I: Heparanase cooperates with Ras
to drive breast and skin tumorigenesis. Cancer Res. 74:4504–4514.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fernandes dos Santos TC, Gomes AM,
Paschoal ME, Stelling MP, Rumjanek VM, Junior AR, Valiante PM, Madi
K, Pereira de Souza HS, Pavão MS, et al: Heparanase expression and
localization in different types of human lung cancer. Biochim
Biophys Acta. 1840:2599–2608. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Poon IK, Goodall KJ, Phipps S, Chow JD,
Pagler EB, Andrews DM, Conlan CL, Ryan GF, White JA, Wong MK, et
al: Mice deficient in heparanase exhibit impaired dendritic cell
migration and reduced airway inflammation. Eur J Immunol.
44:1016–1030. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shteingauz A, Boyango I, Naroditsky I,
Hammond E, Gruber M, Doweck I, Ilan N and Vlodavsky I: Heparanase
enhances tumor growth and chemoresistance by promoting autophagy.
Cancer Res. 75:3946–3957. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lv Q, Zhu D, Zhang J, Yi Y, Yang S and
Zhang W: Association between six genetic variants of IL-17A and
IL-17F and cervical cancer risk: A case-control study. Tumour Biol.
36:3979–3984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lü QY, Zhang W, Cheng J, Zhang WT and
Zhong YJ: Effect on invasion ability of cervical cancer cells after
silence heparanase gene expression in HeLa cells. Zhonghua Fu Chan
Ke Za Zhi. 48:532–537. 2013.In Chinese.
|
|
22
|
Chen RJ, Shun CT, Yen ML, Chou CH and Lin
MC: Methyltransferase G9a promotes cervical cancer angiogenesis and
decreases patient survival. Oncotarget. 8:62081–62098.
2017.PubMed/NCBI
|
|
23
|
Li X, Song Y, Liu F, Liu D, Miao H, Ren J,
Xu J, Ding L, Hu Y, Wang Z, et al: Long non-coding RNA MALAT1
promotes proliferation, angiogenesis, and immunosuppressive
properties of mesenchymal stem cells by inducing VEGF and IDO. J
Cell Biochem. 118:2780–2791. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu X, Er K, Mao C, Yan Q, Xu H, Zhang Y,
Zhu J, Cui F, Zhao W and Shi H: miR-203 suppresses tumor growth and
angiogenesis by targeting VEGFA in cervical cancer. Cell Physiol
Biochem. 32:64–73. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fernandes JV, DE Medeiros Fernandes TA, DE
Azevedo JC, Cobucci RN, DE Carvalho MG, Andrade VS and DE Araújo
JM: Link between chronic inflammation and human
papillomavirus-induced carcinogenesis (Review). Oncol Lett.
9:1015–1026. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He G and Karin M: NF-κB and STAT3 - key
players in liver inflammation and cancer. Cell Res. 21:159–168.
2011. View Article : Google Scholar
|
|
27
|
Vreys V and David G: Mammalian heparanase:
What is the message? J Cell Mol Med. 11:427–452. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chang YH, Yu CW, Lai LC, Tsao CH, Ho KT,
Yang SC, Lee H, Cheng YW, Wu TC and Shiau MY: Up-regulation of
interleukin-17 expression by human papillomavirus type 16 E6 in
nonsmall cell lung cancer. Cancer. 116:4800–4809. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hirshoren N, Bulvik R, Neuman T,
Rubinstein AM, Meirovitz A and Elkin M: Induction of heparanase by
HPV E6 oncogene in head and neck squamous cell carcinoma. J Cell
Mol Med. 18:181–186. 2014. View Article : Google Scholar :
|
|
30
|
Bowers JS, Nelson MH, Kundimi S, Bailey
SR, Huff LW, Schwartz KM, Cole DJ, Rubinstein MP and Paulos CM:
Dendritic cells in irradiated mice trigger the functional
plasticity and antitumor activity of adoptively transferred Tc17
cells via IL12 signaling. Clin Cancer Res. 21:2546–2557. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yan B, Liu Y, Bai H, Chen M, Xie S, Li D,
Liu M and Zhou J: HDAC6 regulates IL-17 expression in T
lymphocytes: Implications for HDAC6-targeted therapies.
Theranostics. 7:1002–1009. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin Z, Bazzaro M, Wang MC, Chan KC, Peng S
and Roden RB: Combination of proteasome and HDAC inhibitors for
uterine cervical cancer treatment. Clin Cancer Res. 15:570–577.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pikarsky E, Porat RM, Stein I, Abramovitch
R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and
Ben-Neriah Y: NF-kappaB functions as a tumour promoter in
inflammation-associated cancer. Nature. 431:461–466. 2004.
View Article : Google Scholar : PubMed/NCBI
|
